STRIVE Project (S02A): Immunocompromised Severe Acute Respiratory (IC-SARI)

This is a project conducted using the STRIVE Observational master protocol (STRIVE 002).

This study will enroll adults with a moderate-to-severe immunocompromising condition who are admitted to the hospital with a severe acute respiratory infection (SARI). The study will advance knowledge on the pathogens most commonly causing SARI among immunocompromised adults globally and provide information on the clinical outcomes of patients with these infections.

IC-SARI ClinicalTrials.gov identifier: NCT07069400